The Point of Care Technology Market is being reshaped by the transition toward decentralized and patient-centric healthcare. Valued at USD 34 billion in 2024, the market increased to USD 35.2 billion in 2025 and is forecast to reach USD 50 billion by 2035. The shift toward rapid testing and greater healthcare accessibility is creating opportunities for manufacturers of diagnostic devices, software, and supporting technologies.

Portable and handheld diagnostic systems are becoming particularly important. Their ability to provide testing outside conventional laboratory environments makes them useful for hospitals, ambulatory settings, remote locations, and home healthcare. Greater consumer preference for convenience and early detection is also encouraging manufacturers to develop easier-to-use point-of-care solutions.

The growing prevalence of chronic diseases is another major market driver. Glucose monitoring devices are projected to increase from USD 8 billion in 2024 to USD 12 billion by 2035, highlighting the continuing importance of point-of-care tools in diabetes management. Cardiac monitoring and infectious disease testing represent additional areas where rapid results can support healthcare delivery.

Connectivity is also becoming a defining feature of the market. Point-of-care devices can increasingly be connected with digital health platforms, telehealth services, and remote monitoring systems. Interoperability between devices and healthcare information systems can help providers use diagnostic information more effectively.

The market's future will depend on the ability of companies to combine portability, accuracy, connectivity, and affordability. Partnerships between technology companies and healthcare organizations may accelerate the development of next-generation solutions, while AI-driven analytics and IoT integration could further expand the role of point-of-care technology.